ReviewCurrent opinion in virology2021

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19.

George R Painter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.